Cystic Fibrosis No Cure Yet, But Treatment Advances Continue Course for physician is organized by ContinuingEducation.com - OnCourse Learning Corporation and will be held during Aug 13, 2012 - Mar 22, 2020.
The target audience for this medical event is intended for multiple professions, including nurses, physicians and physical therapists. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Course Description :
Cystic fibrosis is a genetic disorder. The primary manifestations include progressive obstructive lung disease and pancreatic insufficiency, but patients also may experience chronic sinusitis, nasal polyps, malnutrition, distal intestinal obstructive syndrome, diabetes, liver cirrhosis, pancreatitis, gallstones, and infertility. To have cystic fibrosis, a child must inherit two abnormal cystic fibrosis genes, one from each parent. The parents usually have just one abnormal gene, are asymptomatic, and are called carriers. Each time two carriers have a child, there is a 25% chance the baby will have cystic fibrosis, a 50% chance the baby will be a healthy carrier, and a 25% chance the baby will be a healthy noncarrier. This module provides updated information on the treatment and management of people with cystic fibrosis.
Conference Objectives are :
The goal of this cystic fibrosis continuing education module is to help nurses, physicians, and physical therapists gain a deeper understanding of cystic fibrosis and the treatments available, as well as to become informed about the latest research. After studying the information presented here, you will be able to:
• Describe the basic defect that causes cystic fibrosis and how it affects different organ systems
• Identify three therapies for the management of pulmonary and GI disease in patients with cystic fibrosis
• Explain teaching and support responsibilities
• Discuss research and the future of cystic fibrosis
Pulmonary Medicine, Genetics, Pediatrics Child Abuse